Phase I study of gemcitabine given weekly as a short infusion for non-small cell lung cancer: results and possible immune system-related mechanisms by Levitt, M.L, Kassem, B, Gooding, W.E, Miketic, L.M, Landreneau, R.J, Ferson, P.F, Keenan, R, Yousem, S.A, Lindberg, C.A, Trenn, M.R, Ponas, R.S, Tarasoff, P, Sabatine, J.M, Friberg, D, Whiteside, T.L

Get full text